Trial intelligence / Profile preview

Esketamine ED50 with Alfentanil for Pediatric Facial Laser Treatment

NCT06294639Not yet recruiting

Sponsor
Air Force Medical University
Start
Mar 2024
Primary completion
Mar 2025
Modality
Small Molecules
01

Overview

Single-arm trial of esketamine in Anesthesia, sponsored by Air Force Medical University. Primary endpoint: half effective dose of inhibition of body movement at 5 minutes. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT06294639.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06294639.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call